Announcements Trials
Browse Landscape

Phase

Phase 1 6Phase 1/2 3Phase NA 2Phase 2 2Phase 3 1

Status

Completed 121Terminated 27Unknown 21Active not recruiting 19Recruiting 13Withdrawn 3Not yet recruiting 3Suspended 1Enrolling by invitation 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 7Gastrointestinal 4Thoracic 3Other hematologic neoplasm 3Gynecologic 3Lymphoid 2Genitourinary 2Classical hematology 2Tumor-Agnostic 1Sarcoma 1Plasma cell 1Other 1Myeloid 1Head & Neck 1Dermatologic 1CNS 1

Conditions

Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Suspended × Myeloid × Clear all
NCT01755325 2018-04-25

Phase III Study of Compound Formula Realgar-Indigo Naturalis Plus Imatinib Versus Placebo Plus Imatinib in Adult CML-CP Patients With Ph+

Ruijin Hospital

Phase 3 Suspended
680 enrolled
MyeloidOther hematologic neoplasm

Leukemia, Myelogenous, Chronic, BCR-ABL Positive

Data powered by HemOnc (CC BY 4.0) Colophon âš¡